血清HMGB-1 MIF PDGF预测急性脑出血短期预后的临床价值

doi:10.3969/j.issn.1006-6233.2021.05.018

Abstract
Figure/Table
References
Related Citation (5)

Download: PDF (1392 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To analyze the clinical value of serum high mobility group protein-1 (HMGB-1), macrophage migration inhibitory factor (MIF) and platelet-derived growth factor (PDGF) in predicting short-term prognosis of acute cerebral hemorrhage. Methods: Clinical data of 106 patients with acute cerebral hemorrhage who were treated in the hospital between May 2016 and May 2020 were retrospectively analyzed. According to the severity of nervous system damage, the patients were divided into mild group (NIHSS 1 ~ 4 points, n=23), moderate group (NIHSS 5 ~ 20 points, n=53) and severe group (NIHSS > 20 points, n=30). Meanwhile, 40 healthy controls were made the control group. Three months later, according to the Glasgow Outcome Score (GOS), the patients were divided into favorable prognosis group (GOS 4～5 points, n=60) and bleak prognosis group (GOS ≤ 3 points, n=46). Serum HMGB-1, MIF and PDGF levels were detected, and their clinical value in predicting short-term prognosis of acute cerebral hemorrhage was analyzed with the area under the ROC curve (AUC). Results: Serum HMGB-1, MIF and PDGF levels were higher in patients with cerebral hemorrhage than the control group (P<0.05), higher in the severe group than the mild and moderate groups, higher in the moderate group than the mild group (P<0.05), and higher in the favorable prognosis group than the bleak prognosis group (P<0.05). The sensitivity and AUC area of serum HMGB-1, MIF and PDGF were higher than those of single detection (P<0.05). Conclusion: Serum HMGB-1, MIF and PDGF have high value in predicting short-term prognosis of acute cerebral hemorrhage, which can be used for treatment guidance.

Key words： Acute cerebral hemorrhage Short-term prognosis High mobility group protein-1 Macrophage migration inhibitory factor Platelet-derived growth factor

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LUO Jinlun
	WU Fei
	ZHU Dongqiang
	et al

Cite this article:

LUO Jinlun,WU Fei,ZHU Dongqiang, et al. Clinical Value of Serum HMGB-1 MIF and PDGF in Predicting Short-Term Prognosis of Acute Cerebral Hemorrhage[J]. HeBei Med, 2021, 27(5): 785-789.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2021.05.018 OR http://www.hbyxzzs.cn/EN/Y2021/V27/I5/785

[1] 卓芬,肖华,黄娟娟,等.血清白蛋白及中性粒细胞/淋巴细胞比值预测创伤性脑出血患者预后的价值[J].中国急救医学,2019,39(5):408~411.
[2] Yang A M,Hu B H,Yang B,et al.Effect of minimally invasive drainage surgery on inflammatory mediators,cerebral hemorrhage markers in patients with hypertensive cerebral hemorrhage[J].Journal of Doubtful Cases,2018,017(5):437~441.
[3] Deng T G.Effects of mild hypothermia irrigation fluid on nerve function and oxidative stress during in-tracranial hematoma irrigation[J].Journal of Hainan Medical College,2018,24(22):1975~1978,1983.
[4] 蔡郁,陈小波,朱文清,等.血清中血管内皮生长因子和血小板源性生长因子与胫腓骨骨折患者骨折愈合及关节功能的关系[J].中国卫生检验杂志,2019,29(9):1116~1118.
[5] 王献伟,杜万良,陈盼,等.2007年成人自发性脑内出血治疗指南[J].中国卒中杂志,2007,2(8):702~717.
[6] 张文超,杨雪辉,郭昊,等.高血压脑出血患者立体定向微创颅内血肿清除术的最佳时机分析[J].山东医药,2017,57(20):92~95.
[7] Tiago Gregorio,Pipa S,Cavaleiro P,et al.Original intracerebral hemorrhage score for the prediction of short-term mortality in cerebral hemorrhage:systematic review and meta-analysis[J].Critical Care Medicine,2019,47(6):1.
[8] Jiang L X,Liang Y,Chen W W,et al.Expression and significance of serum NO,IGF-1,MIF levels in acute intracerebral hemorrhage[J].China Medical Journal,2016,13(1):58~61.
[9] 王京娥,陈燕,高山,等.IGF-1,HMGB-1,GSN和MIF水平在高血压脑出血中的意义[J].河北医药,2016,38(18):2733~2736.
[10] 林靖,张炜,郑小强,等.大鼠轻型颅脑损伤后星形胶质细胞与神经元的病理改变[J].中国临床神经外科杂志,2018,23(4):27~30.
[11] 孟亚楠,高萍,李颖蕾,等.高血压性脑出血患者血清高迁移率族蛋白-1、凝溶胶蛋白、胰岛素样生长因子-1和巨噬细胞移动抑制因子水平变化及其对病情和预后的评估价值[J].临床和实验医学杂志,2017,18(2):157~159.